Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Thailand To Begin H1N1 Flu Vaccine Trials In September

This article was originally published in PharmAsia News

Executive Summary

Thailand expects to begin its first human clinical trials of an H1N1 flu vaccine in September, based on anticipated completion of animal trials next week. The director of the Government Pharmaceutical Organization said the company also expects next week to begin producing 300,000 doses of a generic of Roche's Tamiflu (oseltamivir) antiviral for children to treat the H1N1 virus. The generic is to be distributed to hospitals nationwide as the cases of H1N1 rise in Thailand. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts